Prof. Dr. Amal Hassan is a distinguished researcher at the Egyptian Atomic Energy Authority, specializing in pharmacology, radiation biology, and nanomedicine, with a focus on mitigating radiation-induced tissue damage and exploring molecular mechanisms of inflammation. His research encompasses the development of nanostructured lipid carriers, bioactive natural compounds, and metal-based ligands for anticancer and radioprotective applications. With 56 peer-reviewed publications and 747 citations, she has demonstrated significant scholarly impact, reflected in an h-index of 12. Hassan maintains active collaborations with 41 international co-authors, fostering interdisciplinary approaches across pharmacology, toxicology, and biomedical sciences. His work addresses critical challenges in radiation exposure and oxidative stress, contributing to safer therapeutic strategies and advancing translational biomedical research. Through innovative studies on natural and synthetic radioprotective agents, Hassan’s research carries substantial societal relevance, enhancing health outcomes and supporting global efforts in radioprotection, cancer therapy, and environmental safety.
